Biological Pillar 06Ovarian Reserve (AMH) • Gonadotropin Kinetics • Implantation Cytokines • IVF Support

Female Infertility: Ovarian Reserve & Endocrine Biology

“Uncovering the systemic blocks to female fertility”

A biological assessment of ovarian reserve, endocrine regulation, and reproductive immune tolerance. Successful conception and embryo implantation depend on a synchronized endocrine dialogue between the hypothalamic-pituitary-ovarian (HPO) axis, endometrial receptivity, and maternal immune tolerance. Reficio's 4-tier female fertility matrix profiles ovarian reserve (AMH, FSH), ovulatory dynamics (LH, Estradiol, Prolactin, Luteal Progesterone), and autoimmune/cytokine barriers to implantation (Anti-TPO, IL-6, TNF-α).

The 4 Biological Axes of Female Reproductive Health

Coordinated assessment of ovarian reserve, ovulatory kinetics, implantation cytokines, and thyroid autoimmunity.

Axis 01

Ovarian Reserve & Health

AMH, FSH, TSH, Vitamin D, CBC

Axis 02

Ovulation & Follicular Function

LH, Estradiol, Prolactin

Axis 03

Implantation & Inflammatory Biology

Progesterone, IL-6, TNF-α, hs-CRP, Cortisol

Axis 04

Thyroid Autoimmunity

Anti-TPO

Diagnostic Tiers & Pricing Structure

From baseline AMH screening to comprehensive IVF & implantation support matrices.

Screening

Panel 1

₹5,000
  • AMH Ovarian Reserve
  • FSH
  • Vitamin D
Infertility Biology

Panel 2

₹7,500

Adds TNF-α

  • LH & Estradiol
  • Prolactin
  • TNF-α Inflammatory Layer
IVF & Implantation

Panel 3

₹12,000

Adds Progesterone, TNF-α, Cortisol

  • Luteal Progesterone
  • Implantation Cytokine Profile
  • Cortisol Stress Axis
Comprehensive Profile

Panel 4

₹15,000

Uniquely assesses autoimmune/inflammatory barriers to implantation.

  • Anti-TPO Autoimmune Barrier
  • Complete Reproductive Symphony
  • Maximum IVF Support Matrix
Pillar 06 • Biological Education Journey6 Visual Assets & Modules
View Dedicated Pillar Page

Female Infertility & Reproductive Health

“Uncovering the systemic blocks to female fertility”

Successful conception and embryo implantation require synchronized dialogue between the hypothalamic-pituitary-ovarian axis, endometrial receptivity, and maternal immune tolerance. Reficio profiles ovarian reserve, ovulatory kinetics, and implantation barriers.

Stage 1: Scientific & Biological Mechanisms

Sequential physiological and cellular decomposition from the canonical Reficio presentation

1Canonical Slide 021clinical profile
Female Infertility Overview - Slide 21
Click to View Full Size
Source: Reficio Canonical Educational DeckOriginal PNG Asset

Female Infertility Biology Overview

Biological assessment of ovarian reserve, endocrine balance, and implantation tolerance

Anti-Müllerian Hormone (AMH) is produced by pre-antral follicles and provides a cycle-independent indicator of quantitative ovarian reserve, helping fertility specialists gauge reproductive timing and stimulation response.
Clinical Mechanisms & Biological Insights
  • AMH levels reflect the growing follicular pool and remain relatively stable across cycle phases.
  • FSH and Estradiol on Day 2/3 evaluate basal pituitary-ovarian feedback.
Key Biomarkers Mapped in this Module
AMHFSH (Day 2/3)Estradiol (E2)Prolactin
2Canonical Slide 022mechanism
Systemic Blocks to Female Fertility - Slide 22
Click to View Full Size
Source: Reficio Canonical Educational DeckOriginal PNG Asset

Uncovering Systemic Blocks to Fertility

The Biological Orchestra: Endocrine, Inflammatory, Autoimmune, and Metabolic Harmony

Successful pregnancy requires systemic harmony: endocrine balance (PCOS, LH/FSH ratios, Prolactin), endometrial receptivity, and absence of hostile inflammatory/autoimmune activity (Anti-TPO, elevated TNF-α).
Clinical Mechanisms & Biological Insights
  • Subclinical thyroid autoimmunity (Anti-TPO) increases early pregnancy loss risk.
  • Elevated inflammatory cytokines impair endometrial receptivity during the implantation window.
Key Biomarkers Mapped in this Module
Anti-TPOTNF-αLuteal Progesterone (Day 21)Fasting Insulin
3Deep-Dive Assetgenomic deepdive
Reproductive Genomics Workflow - Slide 01
Click to View Full Size
Source: Reficio Canonical Educational DeckOriginal PNG Asset

Reproductive Genomics: Clinical Case for DNA Panels

Workflow convergence: Karyotyping, microarrays, and targeted sequencing in reproductive medicine

Advanced reproductive medicine incorporates targeted genetic panels to assess recurrent pregnancy loss, thrombophilia predispositions, and single-gene carrier states.
Key Biomarkers Mapped in this Module
Thrombophilia Panel (Factor V Leiden, MTHFR, Prothrombin)Karyotype correlation
4Deep-Dive Assetgenomic deepdive
Reproductive Genetic Pathways - Slide 02
Click to View Full Size
Source: Reficio Canonical Educational DeckOriginal PNG Asset

Navigating Reproductive & Immune Genetic Pathways

Thrombophilia, immunological tolerance, and implantation receptor genetics

Maternal-fetal interface genetics involves vascular regulation and HLA-C/KIR immunological tolerance essential for successful placentation.
Key Biomarkers Mapped in this Module
MTHFR C677T/A1298CFactor V LeidenPAI-1
5Deep-Dive Assetgenomic deepdive
Reproductive Genomics Platform Choice - Slide 03
Click to View Full Size
Source: Reficio Canonical Educational DeckOriginal PNG Asset

Technological Infrastructure & Platform Choice

Targeted DNA variant panels vs RNA expression profiling in reproductive workups

Choosing between NGS targeted sequencing and specialized endometrial receptivity arrays depends on clinical history and IVF protocol design.
Key Biomarkers Mapped in this Module
Targeted NGS PanelsTranscriptomic Expression Arrays

Core Diagnostic Biomarker Axes

Coordinated multi-pathway laboratory parameters evaluated across this biological pillar

Axis 01: Ovarian Reserve & Follicular Dynamics

AMH (Anti-Müllerian Hormone), FSH (Day 2/3), Estradiol (E2)

Axis 02: Ovulatory & Luteal Kinetics

LH, Prolactin, Mid-Luteal Progesterone (Day 21)

Axis 03: Implantation Immunology & Cytokines

TNF-α, IL-6, hs-CRP, Vitamin D

Axis 04: Thyroid & Autoimmune Fertility Barriers

TSH, Free T3, Free T4, Anti-TPO, Antiphospholipid Screen

Associated Clinical Indicators

Common systemic presentations associated with this pillar:

• Difficulty conceiving (>12 months or >6 months if >35y)• Irregular or absent menstrual cycles (oligomenorrhea/amenorrhea)• History of recurrent biochemical or clinical implantation failure• Assessing reproductive timelines and ovarian reserve baseline
Stage 3: Diagnostic Panel Tier Architecture

Female Infertility Diagnostic Architecture

Female Infertility Panel Options - Slide 23
Click to View Architecture Full Size
Diagnostic Comparison ArchitectureCanonical Asset
Reficio provides Panel 1 Screening (₹5,000 with AMH, FSH, Vitamin D), Panel 2 Infertility Biology (₹7,500 with LH, Estradiol, Prolactin, TNF-α), Panel 3 IVF & Implantation (₹12,000 with Luteal Progesterone, Implantation Cytokines, Cortisol), and Panel 4 Comprehensive Profile (₹15,000 with Anti-TPO and complete reproductive matrix).
Key Included Biomarkers Across Tiers
AMHFSHLHEstradiolProlactinProgesteroneAnti-TPOTNF-αIL-6
  • Tier 1 confirms ovarian reserve baseline.
  • Tier 3 and 4 evaluate ovulatory confirmation and immune implantation readiness.

Frequently Asked Questions: Fertility Testing

Clinical considerations for reproductive hormone workups and cycle timing.

Fertility & Reproductive Notice:Hormonal concentrations are cycle-dependent. Diagnostic interpretations should be correlated with menstrual cycle tracking, ultrasound imaging (e.g. Antral Follicle Count), and consultation with a reproductive endocrinologist or gynecologist.